TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for FOLH1
check button Gene summary
Basic gene informationGene symbolFOLH1
Gene namefolate hydrolase (prostate-specific membrane antigen) 1
SynonymsFGCP|FOLH|GCP2|GCPII|NAALAD1|NAALAdase|PSM|PSMA|mGCP
CytomapUCSC genome browser: 11p11.2
Type of geneprotein-coding
RefGenesNM_001014986.1,
NM_001193471.1,NM_001193472.1,NM_001193473.1,NM_004476.1,
DescriptionN-acetylated alpha-linked acidic dipeptidase 1N-acetylated-alpha-linked acidic dipeptidase INAALADase Icell growth-inhibiting gene 27 proteinfolylpoly-gamma-glutamate carboxypeptidaseglutamate carboxylase IIglutamate carboxypeptidase 2glutamate car
Modification date20141222
dbXrefs MIM : 600934
HGNC : HGNC
Ensembl : ENSG00000086205
HPRD : 02961
Vega : OTTHUMG00000166625
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_FOLH1
BioGPS: 2346
PathwayNCI Pathway Interaction Database: FOLH1
KEGG: FOLH1
REACTOME: FOLH1
Pathway Commons: FOLH1
ContextiHOP: FOLH1
ligand binding site mutation search in PubMed: FOLH1
UCL Cancer Institute: FOLH1
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesTiGER,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Prostate
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)PRAD
Reference showing the relevant tissue of FOLH1
Description by TissGene annotations
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for FOLH1

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
KIRC3.1069530011.6441516121.4628013893.08E-099.83E-09
PRAD6.8522115484.1911730862.6610384621.02E-079.64E-07
LUSC0.458436171-1.0433069671.5017431373.55E-068.45E-06
THCA-0.572735747-3.2438560862.6711203391.38E-183.82E-17
KIRP-1.2152410971.694055778-2.9092968754.62E-083.03E-07
BRCA-0.1939529940.918562796-1.1125157898.17E-092.72E-08
LIHC1.6197757783.531887778-1.9121121.78E-081.50E-07
KICH-0.2482962221.087431778-1.3357280.001370.002892222


Top
TissGene-miRNA for FOLH1

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for FOLH1
TissGeneSNV for FOLH1

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.D158YLUAD3
p.R281HUVM3
p.R281HPCPG2
p.R565QTHCA2
p.A628SLUAD2
p.E480KSKCM2
p.G692ESKCM2
p.R519ILUAD2
p.P234LHNSC1
p.E424DESCA1
p.K485RLGG1
p.A217TDLBC1
p.R281CUCEC1
p.S31TSKCM1
p.E168KHNSC1
p.R580*KICH1
p.L233FLGG1
p.G168RESCA1
p.I456VSTAD1
p.D244NCESC1
p.I676MBLCA1
p.I708MESCA1
p.L291IPAAD1
p.K178*SARC1
p.A263SSKCM1
p.D99YREAD1
p.F418IUCEC1
p.N574SCOAD1
p.T86RPAAD1
p.Q340RSTAD1
p.K718NESCA1
p.E102QUCEC1
p.K500ELUSC1
p.S626IPAAD1
p.A601TLUSC1
p.R580*GBM1
p.D173YLUAD1
p.E522QLUSC1
p.Y356DLUAD1
p.V177GSTAD1
p.C597YESCA1
p.Q79HUCEC1
p.K703NESCA1
p.I693MESCA1
p.A11PLIHC1
p.G493DCOAD1
p.P110SSKCM1
p.I717MESCA1
p.V358MUCEC1
p.S477FSKCM1
p.R527QOV1
p.N42YLUAD1
p.D173NSTAD1
p.G702RLUSC1
p.E276XTHYM1
p.G349RSKCM1
p.G209ALUAD1
p.E701KSKCM1
p.G206RSTAD1
p.R669KSKCM1
p.E409DESCA1
p.S628*LUSC1
p.Q203*SKCM1
p.G493DLGG1
p.P643LSKCM1
p.Q79HCESC1
p.E64AUCEC1
p.G209RSKCM1
p.D106NUCEC1
p.M669IUCEC1
p.Y341DLUAD1
p.Y677CLUAD1
p.F75SBLCA1
p.R512*SKCM1
p.G306RSKCM1
p.S611IPAAD1
p.K545RKIRC1
p.G196VSKCM1
p.G503ESKCM1
p.T624KESCA1
p.H538DLUAD1
p.E712QSKCM1
p.G211XESCA1
p.R17CBLCA1
p.G283*LUAD1
p.S695GLUSC1
p.K622RLUAD1
p.E183*LUAD1
p.H381YSKCM1
p.M1KLUAD1
p.L5FHNSC1
p.M494ILUAD1
p.R730KUCEC1
p.K479EUCEC1
p.G665ESKCM1
p.E137*HNSC1
p.P66LSKCM1
p.V719ASTAD1
p.R166QSKCM1
p.A535TUCEC1
p.I691MLUAD1
p.G250*LUAD1
p.H280NLUAD1
p.I693LLUAD1
p.P249LHNSC1
p.E422DCOAD1
p.E152*HNSC1
p.D158NTHCA1
p.Q203LLUAD1
p.G196*ESCA1
p.L306IPAAD1
p.R281LLUSC1
p.A593VCOAD1
p.G687RLUAD1
p.D581HLUAD1
p.N444KSARC1
p.D230HHNSC1
p.I732MESCA1
p.D705NSKCM1
p.G235*LUAD1
p.G153RESCA1
p.G241RSKCM1
p.G267ESKCM1
p.C582YESCA1
p.P489SSKCM1
p.D158NSKCM1
p.S575FSKCM1
p.R266CSTAD1
p.M601ISKCM1
p.D699NSKCM1
p.T528IBLCA1
p.K637RLUAD1
p.S30FSKCM1
p.L92PSTAD1
p.N153SUCEC1
p.N444KSKCM1
p.N121SBRCA1
p.V588FLUAD1
p.G267RSKCM1
p.R590KBLCA1
p.Q288ESTAD1
p.D470NSKCM1
p.D505NSKCM1
p.A643SLUAD1
p.L143SLIHC1
p.Y445CSKCM1
p.E425VBRCA1
p.A163SLUSC1
p.G191RSKCM1
p.A735DLUAD1
p.M669LUCEC1
p.R280MLUAD1
p.G211VSTAD1
p.G248VHNSC1
p.T71RPAAD1
p.E22DCESC1
p.A728VLUAD1
p.V675ISKCM1
p.K56RLUAD1
p.R266HKIRP1
p.K684NPRAD1
p.S619FSKCM1
p.G514*LUAD1
p.R17CCOAD1
p.T624KLUSC1
p.Q239HHNSC1
p.M177ISARC1
p.D215HHNSC1
p.R511_spliceLUSC1
p.E130KLUAD1
p.G311CHNSC1
p.Q203XSKCM1
p.I96FCESC1
p.G296CHNSC1
p.S517YLUSC1
p.E168*LUAD1
p.R266CLUAD1
p.E421DCOAD1
p.Y625DBRCA1
p.R265MLUAD1


Top
TissGeneCNV for FOLH1

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for FOLH1

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP
Chimerdb3.0FusionScanPRADTCGA-G9-6384-01AFOLH1-FOLH1BOut-of-Framechr11:49179503chr11:89413776


Top
TissGeneNet for FOLH1

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
FOLH1, MME, EGR1, AR, RPS3, MTAP (tumor)FOLH1, MME, EGR1, AR, RPS3, MTAP (normal)
bullet pointbullet point


Top
TissGeneProg for FOLH1

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for FOLH1
TissGeneDrug for FOLH1

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status
DB00089CapromabOther/unknownBiotechApproved


Top
TissGeneDisease for FOLH1

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0376358Malignant neoplasm of prostate122BeFree,GAD
umls:C0600139Prostate carcinoma120BeFree
umls:C0027627Neoplasm Metastasis12BeFree
umls:C1519666Tumor-Associated Vasculature11BeFree
umls:C0033578Prostatic Neoplasms9BeFree,CTD_human,LHGDN
umls:C0007112Adenocarcinoma of prostate5BeFree
umls:C0280100Solid tumour5BeFree
umls:C1527249Colorectal Cancer5BeFree,GAD
umls:C0001418Adenocarcinoma4BeFree,LHGDN
umls:C0009402Colorectal Carcinoma4BeFree
umls:C0598608Hyperhomocysteinemia4BeFree,GAD
umls:C0936223Metastatic Prostate Carcinoma4BeFree
umls:C1704272Benign Prostatic Hyperplasia4BeFree
umls:C0006142Malignant neoplasm of breast3BeFree
umls:C0596263Carcinogenesis3BeFree
umls:C0678222Breast Carcinoma3BeFree
umls:C1956346Coronary Artery Disease3BeFree
umls:C0007222Cardiovascular Diseases2BeFree,GAD
umls:C0010068Coronary heart disease2GAD
umls:C0027794Neural Tube Defects2GAD
umls:C0035335Retinoblastoma2BeFree
umls:C0036341Schizophrenia2BeFree
umls:C0038454Cerebrovascular accident2BeFree,GAD
umls:C0080178Spina Bifida2BeFree,GAD
umls:C0153690Secondary malignant neoplasm of bone2BeFree
umls:C0178874Tumor Progression2BeFree
umls:C0684249Carcinoma of lung2BeFree
umls:C0740457Malignant neoplasm of kidney2BeFree
umls:C1328504Hormone refractory prostate cancer2BeFree
umls:C1378703Renal carcinoma2BeFree
umls:C1519176Salivary Gland Pleomorphic Adenoma2BeFree
umls:C3495426Homocysteinemia2BeFree
umls:C0001168Complete obstruction1BeFree
umls:C0003469Anxiety Disorders1BeFree
umls:C0004114Astrocytoma1BeFree
umls:C0007131Non-Small Cell Lung Carcinoma1BeFree
umls:C0007786Brain Ischemia1GAD
umls:C0008625Chromosome Aberrations1GAD
umls:C0008924Cleft Lip1GAD
umls:C0008925Cleft Palate1GAD
umls:C0009404Colorectal Neoplasms1LHGDN
umls:C0011570Mental Depression1BeFree
umls:C0011581Depressive disorder1BeFree
umls:C0012860DNA Damage1GAD
umls:C0016412Folic Acid Deficiency1GAD
umls:C0017636Glioblastoma1BeFree
umls:C0019340Herpes NOS1BeFree
umls:C0020538Hypertensive disease1BeFree,GAD
umls:C0022661Kidney Failure, Chronic1GAD,LHGDN
umls:C0023449Acute lymphocytic leukemia1BeFree
umls:C0024117Chronic Obstructive Airway Disease1BeFree
umls:C0024623Malignant neoplasm of stomach1GAD
umls:C0025007Measles1BeFree
umls:C0026764Multiple Myeloma1BeFree
umls:C0027051Myocardial Infarction1BeFree
umls:C0031157Peritonsillar Abscess1BeFree
umls:C0031485Phenylketonurias1GAD
umls:C0038160Staphylococcal Infections1BeFree
umls:C0039614Tetanus1BeFree
umls:C0040336Tobacco Use Disorder1GAD
umls:C0042769Virus Diseases1BeFree
umls:C0042850Vitamin B Deficiency1GAD
umls:C0086132Depressive Symptoms1BeFree
umls:C0149925Small cell carcinoma of lung1BeFree
umls:C0162871Aortic Aneurysm, Abdominal1GAD
umls:C0238339Hereditary pancreatitis1BeFree
umls:C0242379Malignant neoplasm of lung1BeFree
umls:C0278838Prostate cancer recurrent1BeFree
umls:C1739363Prostatic Hypertrophy1BeFree
umls:C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma1BeFree
umls:C3806347Hyperhomocystinemia1GAD